Clinical Trial Update: EVE TRIAL , ALMA SYSTAM [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial called EVE TRIAL, ALMA SYSTAM, sponsored by ResQ Medical Ltd, is currently recruiting for postpartum hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• ALMA SYSTAM
• EVE TRIAL

Snippet

Sponsor: ResQ Medical Ltd | Conditions: Postpartum Haemorrhage (PPH), PPH | Phase 3 | Status: RECRUITING